Neuropsychological evaluation of the child
Neuropsychological evaluation of the child
复制标题
儿童的神经心理学评估
DOI:
10.1002/ana.20046
复制
发表时间:
2004
影响因子:
11.2
通讯作者:
L. Speedie
中科院分区:
文献类型:
--
作者:
L. Speedie
Mild Cognitive Impairment represents the first cohesive review of all aspects of mild cognitive impairment (MCI), a clinical syndrome which is rapidly emerging as one of the major clinical challenges to neurologists in this decade. MCI is a controversial concept: is it a disease state of its own, or simply an earlier stage of Alzheimer’s disease, or conceptionally best viewed as a high-risk state for Alzheimer’s disease, or a transient label that will be doomed as being too vague, fuzzy, and heterogeneous? Clinical neurologists are certainly being asked to see increasing numbers of elderly patients with increasingly mild degrees of memory loss, often driven by a growing public awareness of Alzheimer’s disease as a now treatable condition. This flow of MCI patients could turn into a torrent if current trials of cholinesterase inhibitors such as donepezil in MCI yield positive results! For this reason alone, Mild Cognitive Impairment should be of considerable interest to both community and academic neurologists as well as geriatricians and geriatric psychiatrists. Petersen has assembled a strong set of writers to cover all aspects of the MCI question. An excellent first section addresses the complex clinical and conceptual problems surrounding MCI and fairly presents the concept in its historical framework. Petersen acknowledges that there is considerable confusion surrounding this transition state between normal aging and dementia and discusses the main contributing factors, the heterogeneity of patients with MCI, the different sources of study participants, uncertainty regarding the limits of “normal aging,” and the use of different rating scales for diagnosis. There are strong chapters addressing the varied neuropsychiatric syndromes that present in early AD (by Jeff Cummings) and detailed reviews of the pathology and neuroimaging of the MCI state and early Alzheimer’s disease. In addition, there are a set of chapters by neuropsychologists from the Mayo Clinic (Smith and Ivnik) and Syracuse and Albert Einstein Universities (Sliwinski, Lipton, Buschke, and Wasylyshyn) addressing the crucial issue of how we can define “normality” in the cognitive functioning of the elderly. The potential of sophisticated neuropsychological approaches to “shore us” the validity of MCI is emphasized. Although the uninitiated may find these two chapters on cognitive aging hard reading, the chapters will intrigue dementia specialists and effectively demonstrate that complementary skills of neurologists and psychologists are needed in MCI.Ultimately, neurologists hope we will have simple predictive tests that will indicate which elderly individuals will develop Alzheimer’s disease during life (along with effective therapies that can prevent this). Until such time, however, MCI represents the transitional zone which is likely to increasingly become the target for disease: modifying medications for AD. Any neurologist reading Mild Cognitive Impairment will be well prepared for the multitude of MCI